Drug:
Reaction: HYPERTENSION
20250101 - 20251231
No. 401 - 500
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
401 | 25086075 |
US |
80 | 2 |
Infection, Ventricular extrasystoles, Condition aggravated, Hypertension, |
||||
UPADACITINIB, PREDNISONE, |
||||
402 | 25086086 |
CA |
46 | 2 |
Abdominal discomfort, Abdominal pain upper, Abdominal pain, Adverse drug reaction, Adverse event, Asthenia, Blepharospasm, Blister, Blood cholesterol increased, Bursitis, Confusional state, Deep vein thrombosis postoperative, Depression, Diarrhoea, Dizziness, Dry mouth, Duodenal ulcer perforation, Facet joint syndrome, Folliculitis, Gastrooesophageal reflux disease, Hypercholesterolaemia, Hypertension, Impaired healing, Inflammation, Irritable bowel syndrome, Maternal exposure during pregnancy, |
||||
SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ETANERCEPT, CANDESARTAN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, GOLIMUMAB, LAMOTRIGINE, MIRABEGRON, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, APREMILAST, APREMILAST, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RANITIDINE HYDROCHLORIDE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
403 | 25086219 |
US |
29 | 1 |
Condition aggravated, Hypertension, |
||||
TOFACITINIB, |
||||
404 | 25086238 |
GB |
44 | 1 |
Petit mal epilepsy, Retrograde ejaculation, Loss of consciousness, Hallucination, auditory, Erectile dysfunction, Testicular pain, Testicular atrophy, Sexual life impairment, Ejaculation failure, Hypoacusis, Excessive sexual fantasies, Stress, Semen volume decreased, Skin exfoliation, Sexual dysfunction, Amnesia, Dysuria, Mental disorder, Malaise, Libido decreased, Weight increased, Insomnia, Constipation, Headache, Alopecia, Hypertension, |
||||
OLANZAPINE, ARIPIPRAZOLE, ARIPIPRAZOLE, ARIPIPRAZOLE, CLOZAPINE, AMISULPRIDE, AMISULPRIDE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
405 | 25086396 |
CA |
2 | |
General symptom, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Liver injury, Lower respiratory tract infection, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Musculoskeletal stiffness, Myositis, Nasopharyngitis, Nausea, Oedema, Pain, Pain in extremity, |
||||
SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ADALIMUMAB-ADAZ, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DICLOFENAC SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, NAPROXEN, NAPROXEN SODIUM, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, PHENYLEPHRINE HYDROCHLORIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, CALCIUM CARBONATE, VITAMIN C, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, LORAZEPAM, CAFFEINE CITRATE, |
||||
406 | 25086479 |
JP |
6 | 1 |
Device breakage, Hypertension, |
||||
FRUQUINTINIB, |
||||
407 | 25086483 |
US |
55 | 2 |
Hypertension, Nausea, |
||||
ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, |
||||
408 | 25086510 |
JP |
||
Atrioventricular block complete, Hypertension, Dyslipidaemia, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, MONTELUKAST SODIUM, MONTELUKAST, THEOPHYLLINE, |
||||
409 | 25086517 |
CA |
61 | 2 |
Abdominal pain, Arthralgia, Asthma, Hypertension, Nausea, Off label use, Pneumonia, Pruritus, |
||||
USTEKINUMAB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISONE, MONTELUKAST SODIUM, APIXABAN, CICLESONIDE, FOLIC ACID, |
||||
410 | 25086661 |
KR |
||
Pulmonary embolism, Deep vein thrombosis, Hypertension, Dyspnoea, Dyspnoea, Oedema peripheral, Product use issue, |
||||
TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, LEVOTHYROXINE SODIUM, TRAMADOL HYDROCHLORIDE, AMLODIPINE BESYLATE, URSODIOL, URSOSIOL, URSODIOL, URSOSIOL, |
||||
411 | 25086665 |
US |
||
Hypertension, Feeling abnormal, Hepatic enzyme increased, Malaise, |
||||
BELIMUMAB, NALTREXONE, MAGNESIUM, |
||||
412 | 25089557 |
59 | 1 | |
Angioedema, Anaemia, Hypertension, |
||||
LISINOPRIL, |
||||
413 | 25089606 |
44 | 1 | |
Eosinophilic pneumonia, Respiratory distress, Acute respiratory failure, Myalgia, Asthenia, Vasculitis, Atypical pneumonia, Hypersensitivity, Tachycardia, Hypertension, COVID-19, Nausea, Vomiting projectile, Palpitations, Chromaturia, Decreased appetite, Wheezing, Pleuritic pain, Chest discomfort, Productive cough, |
||||
NALTREXONE, |
||||
414 | 25090104 |
51 | 2 | |
Hypertension, Constipation, |
||||
EPTINEZUMAB-JJMR, |
||||
415 | 25095189 |
|||
Haemoglobin increased, Diabetes mellitus, Hypertension, Hypolipidaemia, Overweight, Drug ineffective, |
||||
DULAGLUTIDE, |
||||
416 | 25081362 |
US |
37 | 2 |
Anaphylactic reaction, Confusional state, Gait inability, Wheezing, Nausea, Eating disorder, Hypertension, Hot flush, |
||||
OFATUMUMAB, |
||||
417 | 25089040 |
43 | ||
Muscular weakness, Dysphagia, Dyspnoea, Hypertension, |
||||
ONABOTULINUMTOXINA, PROGESTERONE, |
||||
418 | 25080605 |
CA |
||
Blood pressure diastolic increased, Blood pressure systolic abnormal, Blood pressure systolic increased, Lupus nephritis, Blood pressure increased, Blood pressure fluctuation, Heart rate decreased, Hypertension, Nausea, Vomiting, Off label use, Intentional product use issue, |
||||
RITUXIMAB, AMLODIPINE, IRBESARTAN, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, COLCHICINE, EPOETIN ALFA, HYDROXYCHLOROQUINE SULFATE, IRBESARTAN, IRON, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, PREDNISONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
419 | 25080618 |
US |
65 | 1 |
Hypertension, Acne, Tooth extraction, Rash, |
||||
DUPILUMAB, |
||||
420 | 25080728 |
CN |
57 | 2 |
Myelosuppression, Hyperbilirubinaemia, Leukopenia, Lymphopenia, Hypertension, |
||||
CARFILZOMIB, |
||||
421 | 25080805 |
US |
68 | 1 |
Therapy change, Fatigue, Depression, Contraindicated product administered, Seasonal allergy, Hypertension, |
||||
ETANERCEPT, PREDNISONE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, DAPAGLIFLOZIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, TIRZEPATIDE, INSULIN GLARGINE AND LIXISENATIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FAMOTIDINE, TAMSULOSIN HYDROCHLORIDE, FINASTERIDE, BENAZEPRIL HYDROCHLORIDE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, TIZANIDINE HYDROCHLORIDE, |
||||
422 | 25080817 |
US |
64 | 2 |
Cataract, Blood cholesterol increased, Cataract operation complication, Liquid product physical issue, Coronary artery disease, Blood cholesterol increased, Vision blurred, Arteriosclerosis, Balance disorder, Low density lipoprotein increased, Cataract, Hypertension, Hemianopia, |
||||
CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80, CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, AND POLYSORBATE 80, CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN, CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, GABAPENTIN, |
||||
423 | 25080937 |
CA |
40 | 2 |
Alopecia, Asthenia, Back injury, Blepharospasm, Blister, Breast cancer stage III, Bursitis, Coeliac disease, Condition aggravated, Confusional state, Depression, Dizziness, Drug hypersensitivity, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Epilepsy, Facet joint syndrome, Fall, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Lip dry, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle spasms, Muscle injury, Muscular weakness, Musculoskeletal stiffness, Nasopharyngitis, Neck pain, Night sweats, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Psoriatic arthropathy, Rash, Rheumatic fever, Sleep disorder, Stomatitis, Synovitis, Systemic lupus erythematosus, |
||||
SECUKINUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ALENDRONATE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERENUMAB-AOOE, INFLIXIMAB, INFLIXIMAB, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHYLPREDNISOLONE, APREMILAST, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, |
||||
424 | 25080983 |
SK |
||
Neutropenia, Hypertension, Atrial fibrillation, Pneumonia, Infection, Thrombocytopenia, Leukocytosis, Petechiae, Diarrhoea, Rash, Rash, Hyponatraemia, Haemoptysis, |
||||
IBRUTINIB, VENETOCLAX, |
||||
425 | 25081147 |
US |
67 | 1 |
Device leakage, Heart rate increased, Hypertension, Product odour abnormal, |
||||
ALBUTEROL SULFATE, |
||||
426 | 25076870 |
GB |
44 | 1 |
Petit mal epilepsy, Erectile dysfunction, Sexual dysfunction, Ejaculation failure, Weight increased, Stress, Malaise, Mental disorder, Retrograde ejaculation, Sexual life impairment, Amnesia, Alopecia, Testicular atrophy, Insomnia, Libido decreased, Semen volume decreased, Sexual dysfunction, Dysuria, Hallucination, auditory, Testicular pain, Loss of consciousness, Skin exfoliation, Hypoacusis, Hypertension, Constipation, Excessive sexual fantasies, Headache, |
||||
OLANZAPINE, ARIPIPRAZOLE, ARIPIPRAZOLE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), ARIPIPRAZOLE, CLOZAPINE, AMISULPRIDE, AMISULPRIDE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, |
||||
427 | 25077231 |
US |
||
Vision blurred, Tremor, Musculoskeletal stiffness, Muscle rigidity, Fear, Impaired driving ability, Feeling abnormal, Gait disturbance, Hypertension, |
||||
ATENOLOL, LOSARTAN, |
||||
428 | 25077232 |
US |
||
Vitamin D decreased, Hypertension, |
||||
ATENOLOL, |
||||
429 | 25077461 |
DE |
||
Myocardial ischaemia, Deep vein thrombosis, Cardiac arrest, Cardiac failure, Arrhythmia, Hypertension, Cardiac valve disease, Atrioventricular block, Cerebrovascular disorder, Peripheral vascular disorder, Lung disorder, Hypokalaemia, Fall, Fracture, |
||||
ABIRATERONE ACETATE, ENZALUTAMIDE, |
||||
430 | 25077685 |
EE |
56 | 1 |
Atrial fibrillation, Arrhythmia, Hypotension, Tricuspid valve incompetence, Mitral valve incompetence, Epilepsy, Cardiac failure congestive, Cardiac failure, Iron deficiency, Hypertension, |
||||
SACUBITRIL AND VALSARTAN, SACUBITRIL AND VALSARTAN, SACUBITRIL AND VALSARTAN, TORSEMIDE, APIXABAN, METOPROLOL TARTRATE, METOPROLOL, EMPAGLIFLOZIN, SPIRONOLACTONE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, GABAPENTIN, |
||||
431 | 25077799 |
US |
||
Cardiac failure congestive, Hypertension, Atrial fibrillation, |
||||
DAPAGLIFLOZIN, |
||||
432 | 25077877 |
US |
1 | |
Hypertension, Adverse drug reaction, |
||||
PIMAVANSERIN TARTRATE, |
||||
433 | 25077891 |
DE |
60 | 2 |
Myocardial infarction, Coronary artery disease, Coronary angioplasty, Stent placement, Vibration syndrome, Hypoaesthesia, Blood triglycerides increased, Hypertension, Blood cholesterol increased, |
||||
EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, MAGNESIUM, |
||||
434 | 25077901 |
CA |
77 | 2 |
Aortic aneurysm, Haemorrhage, Cardiac disorder, Heart rate increased, Hypertension, Peripheral swelling, Pruritus, Pyrexia, Scratch, Swelling, Urticaria, Wound secretion, Therapeutic product effect incomplete, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, |
||||
435 | 25077981 |
IN |
57 | 1 |
Hypertension, Neoplasm malignant, |
||||
ATEZOLIZUMAB, |
||||
436 | 25078004 |
GB |
44 | 1 |
Petit mal epilepsy, Retrograde ejaculation, Loss of consciousness, Hallucination, auditory, Erectile dysfunction, Testicular pain, Testicular atrophy, Sexual life impairment, Ejaculation failure, Hypoacusis, Excessive sexual fantasies, Stress, Semen volume decreased, Skin exfoliation, Sexual dysfunction, Amnesia, Dysuria, Mental disorder, Malaise, Libido decreased, Weight increased, Insomnia, Constipation, Headache, Alopecia, Hypertension, Epididymal cyst, Hypersomnia, |
||||
OLANZAPINE, ARIPIPRAZOLE, ARIPIPRAZOLE, ARIPIPRAZOLE, CLOZAPINE, AMISULPRIDE, AMISULPRIDE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
437 | 25078005 |
US |
83 | 1 |
Hypertension, |
||||
ABATACEPT, |
||||
438 | 25078584 |
CO |
39 | 2 |
Oesophageal stenosis, Oesophagitis, Vomiting, Hypertension, Syncope, Constipation, Myalgia, Dry skin, Fatigue, |
||||
LENVATINIB, |
||||
439 | 25078726 |
ES |
76 | 2 |
Cataract, Memory impairment, Headache, Nervousness, Limb discomfort, Eye pruritus, Eye pain, Pain in extremity, Visual impairment, Blood glucose fluctuation, Malaise, Tremor, Blood glucose decreased, Hyperhidrosis, Hypoacusis, Abscess limb, Localised infection, Hypertension, Haematological infection, Cardiac disorder, Tendon discomfort, Fatigue, Dyspnoea, Back pain, Pain, Hyperglycaemia, Incorrect dose administered, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, EMPAGLIFLOZIN, |
||||
440 | 25079150 |
CA |
62 | 2 |
Respiratory depression, Tremor, Weight increased, Uterine prolapse, Off label use, Hypertension, Hypotension, Myocardial infarction, Electrolyte imbalance, Urinary tract infection, Hyponatraemia, Aphasia, |
||||
ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, CONJUGATED ESTROGENS, ESTROGENS, CONJUGATED, PRAMIPEXOLE, |
||||
441 | 25079162 |
|||
Arthralgia, Back pain, Fatigue, Weight decreased, Abdominal distension, Faeces soft, Nausea, Cardiac flutter, Hypertension, |
||||
RISANKIZUMAB-RZAA, |
||||
442 | 25079173 |
CA |
56 | 1 |
Serotonin syndrome, Abdominal pain, Agitation, Clonus, Diarrhoea, Hypertension, Nausea, Pyrexia, Tachycardia, Tachypnoea, Vomiting, |
||||
FENTANYL, |
||||
443 | 25079194 |
CN |
81 | |
Cortisol decreased, Hyponatraemia, Hypochloraemia, Hypertension, Glucocorticoid deficiency, |
||||
444 | 25079230 |
CA |
62 | |
Headache, Hypertension, Abdominal discomfort, Infection, Influenza, Lung disorder, Lung hyperinflation, Illness, Obstructive airways disorder, Productive cough, Respiratory disorder, Snoring, Sputum discoloured, Wheezing, Asthma, Full blood count abnormal, Breath sounds abnormal, Bronchiectasis, Dyspnoea, Flatulence, Heart rate increased, Therapeutic product effect incomplete, Drug ineffective, |
||||
FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, MEPOLIZUMAB, MEPOLIZUMAB, ALBUTEROL SULFATE, FLUTICASONE FUROATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, PREDNISONE, PREDNISONE, TIOTROPIUM BROMIDE, IPRATROPIUM BROMIDE, ALBUTEROL SULFATE, |
||||
445 | 25079432 |
AT |
2 | |
Deafness, Hypertension, Dizziness, Hypotension, Headache, Tremor, |
||||
446 | 25079521 |
US |
82 | 2 |
Nausea, Pneumonia, Vomiting, Hypertension, Chest pain, Diarrhoea, |
||||
LENVATINIB, ERGOCALCIFEROL, VANCOMYCIN HYDROCHLORIDE, LOSARTAN POTASSIUM, LOSARTAN, MEDROXYPROGESTERONE ACETATE, ASCORBIC ACID, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ESTRADIOL, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
447 | 25079658 |
DE |
||
Insulin-requiring type 2 diabetes mellitus, Parkinson^s disease, Hypertension, Depression, |
||||
DAPAGLIFLOZIN, |
||||
448 | 25079659 |
US |
79 | 2 |
Off label use, Deep vein thrombosis, Breast mass, Palmar-plantar erythrodysaesthesia syndrome, Tumour pain, Anaemia, Ascites, Constipation, Hypertension, Iron deficiency, Vitamin B12 deficiency, Vitamin D deficiency, Haematocrit decreased, Haemoglobin decreased, Neuroendocrine carcinoma, Abdominal pain, Abnormal loss of weight, Oedema peripheral, Pelvic pain, Small intestinal obstruction, Colon cancer, Neuropathy peripheral, Leukopenia, Metastases to liver, Vomiting, Blood creatinine decreased, Platelet count increased, |
||||
BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, CAPECITABINE, CAPECITABINE, APIXABAN, AMLODIPINE, MECLIZINE HCL 12.5 MG, MECLIZINE, MECLIZINE HYDROCHLORIDE, MECLIZINE HCL 25MG, MECLIZINE HCL 12.5MG, SIMVASTATIN, LATANOPROST, OCTREOTIDE ACETATE, OCTREOTIDE, TRIFLURIDINE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
449 | 25079715 |
CA |
2 | |
Neurological symptom, White blood cell disorder, Eye disorder, Hepatomegaly, Heart rate irregular, Peripheral swelling, Muscle contractions involuntary, Feeling cold, Dry skin, Nocturia, Polyuria, Cognitive disorder, Muscular weakness, Pollakiuria, Palpitations, Dyspnoea, Thirst, Gait disturbance, Chest discomfort, Rash, Musculoskeletal stiffness, Heart rate increased, Drug hypersensitivity, Weight increased, Insomnia, Somnolence, Fatigue, Hypertension, Tardive dyskinesia, Headache, Dystonia, Tremor, Nausea, Adverse drug reaction, Pain, White blood cell count decreased, |
||||
ARIPIPRAZOLE, ARIPIPRAZOLE, ARIPIPRAZOLE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), VALPROIC ACID, LORAZEPAM, OLANZAPINE, HYDROCHLOROTHIAZIDE, |
||||
450 | 25079772 |
FR |
69 | 2 |
Neutropenia, Malignant neoplasm progression, Diarrhoea, Visual impairment, Oedema, Hypertension, Oedema peripheral, |
||||
SELPERCATINIB, GEMCITABINE HYDROCHLORIDE, PEMETREXED, PEMETREXED DISODIUM, CABOZANTINIB, OSIMERTINIB, OSIMERTINIB, TRAMETINIB, CARBOPLATIN, |
||||
451 | 25079908 |
GB |
44 | 1 |
Petit mal epilepsy, Retrograde ejaculation, Loss of consciousness, Hallucination, auditory, Erectile dysfunction, Testicular pain, Testicular atrophy, Sexual life impairment, Ejaculation failure, Hypoacusis, Excessive sexual fantasies, Stress, Semen volume decreased, Skin exfoliation, Sexual dysfunction, Amnesia, Dysuria, Mental disorder, Malaise, Libido decreased, Weight increased, Insomnia, Constipation, Headache, Alopecia, Hypertension, |
||||
CLOZAPINE, OLANZAPINE, AMISULPRIDE, AMISULPRIDE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, ARIPIPRAZOLE, ARIPIPRAZOLE, ARIPIPRAZOLE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
452 | 25079991 |
US |
52 | 2 |
Loss of consciousness, Fatigue, Palpitations, Chest discomfort, Cold sweat, Tremor, Brain fog, Dizziness, Hypertension, Nausea, |
||||
EPTINEZUMAB-JJMR, |
||||
453 | 25080124 |
CA |
44 | 2 |
Respiratory disorder, Liver disorder, Hepatic cirrhosis, Liver injury, Lupus-like syndrome, Rheumatoid arthritis, Pulmonary fibrosis, Breast cancer stage III, Colitis ulcerative, Crohn^s disease, Deep vein thrombosis postoperative, Porphyria acute, Lower respiratory tract infection, Lupus vulgaris, Pericarditis, Pneumonia, Muscular weakness, Psoriatic arthropathy, Retinitis, Grip strength, Ear infection, Drug tolerance decreased, Delirium, Helicobacter infection, Sleep disorder due to a general medical condition, Arthropathy, Asthenia, Gastrointestinal disorder, General physical health deterioration, Blood cholesterol increased, Grip strength decreased, Hand deformity, Gait disturbance, Foot deformity, Hypercholesterolaemia, Folliculitis, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Inflammation, Infusion related reaction, Injury, Fibromyalgia, Irritable bowel syndrome, Joint range of motion decreased, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, FLUOROMETHOLONE, RITUXIMAB, RITUXIMAB, |
||||
454 | 25080156 |
US |
||
Adrenal disorder, Cortisol abnormal, Hypertension, Weight increased, |
||||
RAVULIZUMAB, |
||||
455 | 25080178 |
CN |
98 | 1 |
Generalised tonic-clonic seizure, Pneumonia, Hypertension, Coronary artery disease, Cerebrovascular insufficiency, Cerebellar haemorrhage, |
||||
456 | 25080205 |
CA |
40 | 2 |
Breast cancer stage II, Psoriatic arthropathy, Type 2 diabetes mellitus, Systemic lupus erythematosus, Hepatitis, Liver injury, Epilepsy, Lower respiratory tract infection, Duodenal ulcer perforation, Pneumonia, Pericarditis, Coeliac disease, Rheumatic fever, Pemphigus, Rheumatoid arthritis, Urticaria, Stomatitis, Helicobacter infection, Wound infection, Vomiting, Pain in extremity, Onychomycosis, Blepharospasm, Synovitis, Peripheral swelling, Depression, Hypertension, Hepatic enzyme increased, Blood cholesterol increased, Adverse reaction, Malaise, Hypersensitivity, Grip strength decreased, Alopecia, Headache, Obesity, Peripheral venous disease, Diarrhoea, Nasopharyngitis, Paraesthesia, Lung disorder, Muscular weakness, Dizziness, Asthenia, Musculoskeletal stiffness, Gastrointestinal disorder, Arthropathy, Hand deformity, Injection site reaction, Inflammation, Blister, General physical health deterioration, Bursitis, Mobility decreased, Liver function test increased, Infusion related reaction, Swelling, Memory impairment, Joint swelling, Live birth, Maternal exposure during pregnancy, Intentional product use issue, Normal newborn, Drug-induced liver injury, Irritable bowel syndrome, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, CANDESARTAN, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SECUKINUMAB, SECUKINUMAB, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, VITAMIN C, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, AZATHIOPRINE SODIUM, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, APREMILAST, SECUKINUMAB, |
||||
457 | 25080231 |
CA |
57 | 2 |
Hypertension, Blood pressure increased, Ageusia, Anosmia, Asthma, Oxygen saturation decreased, Productive cough, White coat hypertension, Pneumonia, Malaise, Fatigue, |
||||
TIOTROPIUM BROMIDE, BUDESONIDE, ALBUTEROL SULFATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, MONTELUKAST SODIUM, MONTELUKAST, MONTELUKAST SODIUM, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, |
||||
458 | 25071654 |
CA |
58 | 2 |
Flatulence, Hypertension, Metastases to peritoneum, Uterine mass, Faeces soft, Weight decreased, Pain, Abdominal pain, Decreased appetite, Diarrhoea, Fatigue, Insomnia, Nausea, |
||||
TEMOZOLOMIDE, LANREOTIDE ACETATE, CANDESARTAN, CAPECITABINE, CHOLESTYRAMINE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, HYDROMORPHONE HYDROCHLORIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, NABILONE, |
||||
459 | 25071713 |
US |
67 | 2 |
Skin cancer, Respiratory tract inflammation, Paranasal sinus inflammation, Upper-airway cough syndrome, Hypertension, Product use in unapproved indication, |
||||
RIPRETINIB, RIPRETINIB, RIPRETINIB, |
||||
460 | 25071773 |
US |
77 | 2 |
Hypertension, Drug ineffective, Headache, Product substitution issue, |
||||
VALSARTAN AND HYDROCHLOROTHIAZIDE, VALSARTAN, MAVACAMTEN, FISH OIL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
461 | 25071774 |
US |
2 | |
Flushing, Hypertension, |
||||
VALSARTAN AND HYDROCHLOROTHIAZIDE, VALSARTAN AND HYDROCHLOROTHIAZIDE, VALSARTAN AND HYDROCHLOROTHIAZIDE, |
||||
462 | 25071776 |
US |
66 | 1 |
Hypertension, Influenza, Productive cough, Wheezing, Sleep disorder, Cough, Oxygen saturation decreased, Dizziness, Frustration tolerance decreased, Feeling abnormal, Treatment noncompliance, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, PANTOPRAZOLE SODIUM, DIFLUPREDNATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, FEXOFENADINE HYDROCHLORIDE, NEPAFENAC, SILDENAFIL CITRATE, SILDENAFIL, AMOXICILLIN, LOPERAMIDE HYDROCHLORIDE, ERGOCALCIFEROL, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, FLUTICASONE PROPIONATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, GARLIC, CALCIUM, OXYGEN, 0XYGEN, ONDANSETRON HYDROCHLORIDE, AMBRISENTAN, FERROUS SULFATE, OSELTAMIVIR PHOSPHATE, AMLODIPINE BESYLATE, |
||||
463 | 25071882 |
CA |
52 | 2 |
Cerebral vasoconstriction, Subarachnoid haemorrhage, Thunderclap headache, Hypertension, Rebound nasal congestion, |
||||
DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
464 | 25072085 |
JP |
76 | 1 |
Death, Pain in extremity, Diarrhoea, Hypertension, |
||||
NINTEDANIB, |
||||
465 | 25072163 |
US |
43 | 2 |
Cardiac arrest, Hypertension, Diabetes mellitus, |
||||
OCRELIZUMAB, |
||||
466 | 25072239 |
US |
77 | 2 |
Hypertension, |
||||
APIXABAN, ATENOLOL, |
||||
467 | 25072433 |
US |
33 | 2 |
Tremor, Hypertension, Hyperhidrosis, Nightmare, |
||||
NUSINERSEN, |
||||
468 | 25072559 |
US |
2 | |
Hypertension, |
||||
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
469 | 25072566 |
CA |
2 | |
Hypotension, Hypertension, Mood altered, Weight decreased, Dizziness, Product use issue, Wrong technique in product usage process, |
||||
SEMAGLUTIDE, |
||||
470 | 25072811 |
JP |
6 | 1 |
Angina pectoris, Dizziness, Hypertension, Intentional dose omission, |
||||
VONOPRAZAN FUMARATE, AZILSARTAN KAMEDOXOMIL, AZILSARTAN KAMEDOXOMIL, SACUBITRIL AND VALSARTAN, SACUBITRIL AND VALSARTAN, CLOPIDOGREL BISULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, EZETIMIBE, |
||||
471 | 25072849 |
AU |
66 | 1 |
Hypoxia, Hypertension, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, |
||||
472 | 25072982 |
GB |
15 | 1 |
Serotonin syndrome, Hyperthermia, Sinus tachycardia, Hypertension, Sensory overload, |
||||
LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, TERBINAFINE HYDROCHLORIDE, TERBINAFINE, |
||||
473 | 25073068 |
DE |
1 | |
Atrial fibrillation, Fluid retention, Hypertension, Product use in unapproved indication, |
||||
ALEMTUZUMAB, |
||||
474 | 25073229 |
US |
64 | 1 |
Chest pain, Blood potassium increased, Pain, Hypertension, |
||||
OCRELIZUMAB, |
||||
475 | 25073397 |
FR |
14 | 2 |
Hypertension, Fatigue, Anaemia, Thrombocytopenia, Drug ineffective, Hypothyroidism, Off label use, Diarrhoea, |
||||
AXITINIB, THIOTEPA, ETOPOSIDE, ETOPOSIDE, CARBOPLATIN, |
||||
476 | 25073512 |
CA |
||
Abdominal pain upper, Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Back disorder, Blister, Blood cholesterol increased, Breast cancer stage II, Chest pain, Condition aggravated, Confusional state, Contusion, Decreased appetite, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Drug hypersensitivity, Duodenal ulcer perforation, Dyspepsia, Fatigue, Fluid retention, Fibromyalgia, Folliculitis, Gait disturbance, Gastrointestinal disorder, Gait inability, General physical health deterioration, General symptom, Grip strength decreased, Glossodynia, Hand deformity, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Liver injury, Lower respiratory tract infection, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Musculoskeletal stiffness, Myositis, Nasopharyngitis, Nausea, Oedema, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Pruritus, Psoriatic arthropathy, Psoriasis, Pulmonary fibrosis, Pustular psoriasis, Pyrexia, Rash, Rash vesicular, Rheumatic fever, Rheumatoid factor positive, Rheumatoid arthritis, Sleep disorder, Sinusitis, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Subcutaneous drug absorption impaired, Swelling, Swollen joint count increased, Synovitis, Type 2 diabetes mellitus, Systemic lupus erythematosus, Urticaria, Vomiting, Weight decreased, Weight increased, Wheezing, Wound, X-ray abnormal, Wound infection, |
||||
CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, CALCIUM CARBONATE, ANTACID, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, IODINE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SARILUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, NAPROXEN, NAPROXEN SODIUM, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, OXYCODONE HYDROCHLORIDE, OXYCODONE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, VITAMIN C, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, CALCIUM, ERGOCALCIFEROL, LANSOPRAZOLE, LISINOPRIL, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, SULFASALAZINE, SULFASALAZINE, FISH OIL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, LORAZEPAM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
477 | 25073663 |
US |
||
Hypertension, Depression, Muscle tightness, Headache, Visual impairment, Product substitution issue, |
||||
478 | 25073717 |
GB |
||
Basal ganglia haemorrhage, Lower respiratory tract infection, Sepsis, Hypertension, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, |
||||
479 | 25073817 |
US |
68 | 1 |
Gout, Dry mouth, Product use in unapproved indication, Tremor, Disturbance in attention, Dyspnoea, Depression, Dyskinesia, Fatigue, Gait disturbance, Product dose omission issue, Dizziness, Asthma, Hypertension, Feeling abnormal, Initial insomnia, Musculoskeletal stiffness, Balance disorder, |
||||
DEUTETRABENAZINE, DEUTETRABENAZINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ALBUTEROL SULFATE, BACLOFEN, LORATADINE, LORATADINE TABLET, FLUTICASONE PROPIONATE, TRIPROLIDINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, FLUOROMETHOLONE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, TEZEPELUMAB-EKKO, FAMOTIDINE, LOSARTAN POTASSIUM, LOSARTAN, MONTELUKAST, DEUTETRABENAZINE, PREDNISONE, HYDROCHLOROTHIAZIDE, ERGOCALCIFEROL, |
||||
480 | 25073878 |
CA |
43 | 2 |
Arthralgia, Blister, Drug hypersensitivity, Drug intolerance, Hepatic enzyme increased, Hypercholesterolaemia, Hypertension, Infusion related reaction, Muscle spasms, Pemphigus, Rheumatoid arthritis, Synovitis, Stomatitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Wheezing, Wound infection, Contraindicated product administered, Intentional product use issue, Product use in unapproved indication, Product use issue, Off label use, Treatment failure, Therapeutic product effect decreased, Hand deformity, Leukopenia, Hypertransaminasaemia, Maternal exposure during pregnancy, Hypersensitivity, Joint swelling, Oedema, Deep vein thrombosis postoperative, Psoriatic arthropathy, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, ERENUMAB-AOOE, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, CALCIUM CHLORIDE INJECTION, CALCIUM CHLORIDE, CALCIUM GLUCONATE, CALCIUM GLUCONATE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, GOLIMUMAB, SARILUMAB, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, TOCILIZUMAB, TOCILIZUMAB, CALCIUM CARBONATE, HYDROCORTISONE ACETATE, LORAZEPAM, CAFFEINE, CALCIUM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LANSOPRAZOLE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LISINOPRIL, LORAZEPAM, MAGNESIUM, MELOXICAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PIROXICAM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, RISEDRONATE SODIUM, SULFASALAZINE, FISH OIL, ERGOCALCIFEROL, |
||||
481 | 25073966 |
CA |
53 | 2 |
Asthenia, Asthma, Bladder pain, Blood pressure fluctuation, Blood pressure increased, Blood thyroid stimulating hormone increased, Bronchitis, Cataract, Concussion, Condition aggravated, Cough, Dizziness, Dyspnoea, Ear discomfort, Eye pruritus, Fall, Fatigue, Feeling hot, Gait disturbance, Gastroenteritis, Head banging, Headache, Hypersensitivity, Hypertension, Inappropriate schedule of product administration, Influenza, Lymphadenitis, Lymphadenopathy, Migraine, Mood altered, Nasal pruritus, Nasopharyngitis, Neck pain, Oral pruritus, Paraesthesia, Pneumonitis, Pruritus, Respiratory disorder, Respiratory syncytial virus infection, Respiratory tract congestion, Retinal tear, Salivary hypersecretion, Sensitivity to weather change, Sinusitis, Sneezing, Somnolence, Stress, Swelling, Swelling face, Throat irritation, Thyroid mass, Wound infection fungal, Wrong technique in product usage process, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CICLESONIDE, DIPHENHYDRAMINE HYDROCHLORIDE, CANDESARTAN, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, TERBINAFINE HYDROCHLORIDE, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
482 | 25073999 |
US |
||
Contusion, Skin atrophy, Skin haemorrhage, Eye pain, Hypertension, Eye irritation, |
||||
KENALOG, ESTRADIOL ACETATE, |
||||
483 | 25074622 |
IT |
35 | 1 |
Differentiation syndrome, Cerebral haemorrhage, Cardiac arrest, Hypertension, Generalised tonic-clonic seizure, Depressed level of consciousness, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, AMLODIPINE, FUROSEMIDE, FUROSEMIDE, PREDNISONE, HYDROXYUREA, TRETINOIN, |
||||
484 | 25074692 |
US |
||
Nephrolithiasis, Adrenal cyst, Paraesthesia, Hypoaesthesia, Hypertension, Heart rate increased, |
||||
ACALABRUTINIB, |
||||
485 | 25074733 |
JP |
7 | |
Hypertension, |
||||
PEMBROLIZUMAB, LENVATINIB, |
||||
486 | 25074754 |
US |
2 | |
Pneumonia influenzal, Hypertension, |
||||
DULAGLUTIDE, SEMAGLUTIDE, |
||||
487 | 25075036 |
IN |
3 | 1 |
Thyroxine increased, Blood thyroid stimulating hormone decreased, Tri-iodothyronine increased, Hypertension, Tachycardia, |
||||
LEVOTHYROXINE, |
||||
488 | 25075061 |
PH |
2 | |
Cardiomegaly, Chronic kidney disease, Hypertension, Inappropriate schedule of product administration, Wrong technique in product usage process, Underdose, |
||||
TOLVAPTAN, TOLVAPTAN, |
||||
489 | 25075141 |
CN |
79 | 1 |
Hypertension, |
||||
SOYBEAN OIL, |
||||
490 | 25075173 |
JP |
74 | 2 |
Urinary tract infection, Lung adenocarcinoma, Blood glucose increased, Hypertension, Chronic kidney disease, |
||||
SITAGLIPTIN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
491 | 25075279 |
CA |
40 | 2 |
Abdominal discomfort, Abdominal distension, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Blood cholesterol increased, Coeliac disease, Condition aggravated, Drug intolerance, Drug-induced liver injury, Dyspepsia, Fatigue, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Hepatic enzyme increased, Hypersensitivity, Hypertension, Insomnia, Joint swelling, Malaise, Maternal exposure during pregnancy, Musculoskeletal stiffness, Nail disorder, Product label confusion, Off label use, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, SECUKINUMAB, SECUKINUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, APREMILAST, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE, AZATHIOPRINE SODIUM, BOTULINUM TOXIN TYPE A, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
492 | 25075680 |
US |
63 | 1 |
Osteoarthritis, Liver function test increased, Hypertension, |
||||
UPADACITINIB, AMLODIPINE, |
||||
493 | 25075701 |
CA |
60 | 2 |
Arthralgia, Asthenia, Burning sensation, COVID-19, Cold sweat, Immunodeficiency, Joint swelling, Productive cough, White blood cell count increased, Lower respiratory tract infection, Nasopharyngitis, Pneumonia, Weight increased, Bronchitis, Headache, Hot flush, Hypertension, Drug ineffective, Intentional dose omission, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, FOLIC ACID, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, METHOTREXATE, METHOTREXATE SODIUM, RABEPRAZOLE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
494 | 25075882 |
US |
70 | |
Asthma, Cough, Upper-airway cough syndrome, Overweight, Wheezing, Productive cough, Obstructive airways disorder, Sleep apnoea syndrome, Dyspnoea, Snoring, Insomnia, Ehlers-Danlos syndrome, Hypertension, Gout, Hyperlipidaemia, Back pain, Coronary artery disease, Generalised anxiety disorder, Diverticulum intestinal, Parathyroid hormone-related protein, Prostatitis, Steatohepatitis, Bronchial secretion retention, Acquired ATTR amyloidosis, Nausea, Eosinophil count, Eosinopenia, Emphysema, Pneumonitis, Symptom recurrence, Albumin urine present, |
||||
ALBUTEROL SULFATE, ALBUTEROL, AMLODIPINE, METHOCARBAMOL, FLUTICASONE PROPIONATE, TRIPROLIDINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, HYDRALAZINE HYDROCHLORIDE, LOSARTAN, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, |
||||
495 | 25076071 |
AT |
2 | |
Deafness, Hypertension, Headache, Dizziness, Hypotension, Tremor, |
||||
496 | 25076147 |
CA |
43 | 2 |
Hand deformity, Infusion site reaction, Injury, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Musculoskeletal pain, Liver function test increased, Lung disorder, Helicobacter infection, Memory impairment, Mobility decreased, Muscle injury, Muscle spasms, Nail disorder, Nasopharyngitis, Nausea, Obesity, Hepatic enzyme increased, Glossodynia, Hypercholesterolaemia, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Contraindicated product administered, Intentional product use issue, Off label use, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ATOMOXETINE, ATOMOXETINE, ATOMOXETINE, ABATACEPT, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, LEFLUNOMIDE, LEFLUNOMIDE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, BUPRENORPHINE, CANDESARTAN, CANDESARTAN, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, CYCLOBENZAPRINE, DICLOFENAC, DICLOFENAC SODIUM, ETANERCEPT, AZELAIC ACID, ALENDRONATE SODIUM, HYDROMORPHONE HYDROCHLORIDE, AZATHIOPRINE, AZATHIOPRINE, INFLIXIMAB, INFLIXIMAB, LEFLUNOMIDE, LEVOMILNACIPRAN, MINOCYCLINE, NAPROXEN, NAPROXEN SODIUM, OXYCODONE, PANTOPRAZOLE SODIUM, TOFACITINIB, TOFACITINIB, TOFACITINIB, |
||||
497 | 25076345 |
US |
67 | 1 |
Spinal fracture, Diabetes mellitus, Internal haemorrhage, Atrial fibrillation, Intestinal haemorrhage, Hypertension, Dyspnoea, Sluggishness, Oropharyngeal discomfort, Rash, Fatigue, Insomnia, Osteoporosis, Localised infection, |
||||
PREDNISONE, |
||||
498 | 25076405 |
CA |
7 | 2 |
Adrenal suppression, Cataract subcapsular, Cushingoid, Cytomegalovirus infection, Drug ineffective for unapproved indication, Glomerulosclerosis, Hypertension, Infection, Neuropathy peripheral, Osteoporosis, Proteinuria, Pulmonary toxicity, Renal disorder, Off label use, |
||||
BLEOMYCIN SULFATE, SIROLIMUS, SIROLIMUS, SIROLIMUS, SIROLIMUS, VINCRISTINE SULFATE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, OCTREOTIDE ACETATE, OCTREOTIDE, PREDNISONE, PREDNISONE, PROPRANOLOL HYDROCHLORIDE, TRAMETINIB, |
||||
499 | 25076542 |
US |
68 | 1 |
Depression, Anxiety, Fungal peritonitis, Hypertension, |
||||
500 | 25076558 |
JP |
7 | 2 |
Malignant neoplasm progression, Postrenal failure, Proteinuria, Polydipsia, Vaginal prolapse, Hypertension, Erythema, Hyponatraemia, Decreased appetite, Drug ineffective, |
||||
PEMBROLIZUMAB, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28